|
|
Create Your Blog
View All Blogs
Forums
Blog Entries With Tag: GreeceBlog: Anna's BlogFrom: FatCatAnnaPosted: May 29, 2010
I use Novo Nordisk insulin for the control of my diabetes (NovoRapid here in Canada). I just read online that the Danish company is objecting to Greece's decision to decree ordering a 25% price cut in all medicines. Because of this price cut - Novo Nordisk would run at a loss for supplying their product to diabetics who NEED their insulin products to maintain life! To top it all off, the company feels that if Greece can do this, then other countries will follow suite. OMG, I am just overwhelmed with emotions with knowing that in order to survive we diabetics are at the mercy of the pharmaceutical companies (note to self - stop looking through rose-coloured glasses - wake up and smell the .... $$$ MONEY $$$).
More than 50,000 Greeks with diabetes use Novo Nordisk's product, which is injected via an easy-to-use fountain pen-like device. I love this device, as I'm sure many of you feel the same way. To use regular needles is a pain in the bleep bleep bleep. To read more about this story - which I felt deserved to be posted on my blog page - go to this link (or if you prefer - cut/paste the following link into a new browser window - http://news.bbc.co.uk/2/hi/world/europe/10189367.stm ) Oh, and to add more fuel to the fire - Novo Nordisk will compensate by making available glucagen (used to treat low blood sugars in emergency situations only) free of charge. I think with the removal of their insulin products, that diabetics maybe having the reverse - high blood sugars!
Comments |
 |
 |
 |
 |
 |
Tags: Greece (1) hypo (1) blood glucose (1) BG (1) insulin (1) Novo Nordisk (1) Related posts:Type 1 vs. Type 2 | In a slump and scared | Surviving the Holocaust with Type 1 diabetes | Edmonton man denied insulin for 20 hours | Crack Free #ShowMeYourPump | Jenna and The Hypo Fairy | Wearing a dress with medical gadgets | Pre-op visit with endo at hospital | When You're Hot, You're Hot | I'm so excited |
|
|
|||||||||||||
|
|
|||||||||||||
|